Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients

被引:5
|
作者
Bosas, Paulius [1 ]
Zaleskis, Gintaras [2 ]
Dabkeviciene, Daiva [2 ]
Dobrovolskiene, Neringa [2 ]
Mlynska, Agata [2 ,3 ]
Tikuisis, Renatas [2 ]
Ulys, Albertas [2 ]
Pasukoniene, Vita [2 ,3 ]
Jarmalaite, Sonata [2 ,4 ]
Jankevicius, Feliksas [1 ,5 ]
机构
[1] Vilnius Univ, Fac Med, Inst Clin Med, LT-03101 Vilnius, Lithuania
[2] Natl Canc Inst Lithuania, LT-08406 Vilnius, Lithuania
[3] Vilnius Gediminas Tech Univ, Dept Chem & Bioengn, LT-10223 Vilnius, Lithuania
[4] Vilnius Univ, Life Sci Ctr, Inst Biosci, LT-10257 Vilnius, Lithuania
[5] Vilnius Univ Hosp Santaros Klin, LT-08661 Vilnius, Lithuania
关键词
prostate cancer; prostatectomy; biochemical recurrence; immunophenotyping; ASSISTED RADICAL PROSTATECTOMY; KILLER-CELL ACTIVITY; SUPPRESSOR-CELLS; IMMUNE-RESPONSE; RADIOTHERAPY; LAPAROTOMY; EXPRESSION; GENERATION; RESECTION; OUTCOMES;
D O I
10.3390/jcm10163709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements in peripheral blood and to elucidate if it is associated with biochemical recurrence (BCR) in high risk (HR) and low risk (LR) patients. Methods: Radical prostatectomy (RP) was performed on 108 PCa stage pT2-pT3 patients. Preoperative vs. postoperative (one and three months) immunophenotype profile (T- and B-cell subsets, MDSC, NK, and T reg populations) was compared in peripheral blood of LR and HR groups. Results: The BCR-free survival difference was significant between the HR and LR groups. Postoperative PSA decay rate, defined as ePSA, was significantly slower in the HR group and predicted BCR at cut-off level ePSA = -2.0% d(-1) (AUC = 0.85 (95% CI, 0.78-0.90). Three months following tumor excision, the LR group exhibited a recovery of natural killer CD3 - CD16+ CD56+ cells, from 232 cells/mu L to 317 cells/mu L (p < 0.05), which was not detectable in the HR group. Prostatectomy also resulted in an increased CD8+ population in the LR group, mostly due to CD8+ CD69+ compartment (from 186 cells/mu L before surgery to 196 cells/mu L three months after, p < 001). The CD8+ CD69+ subset increase without total T cell increase was present in the HR group (p < 0.001). Tumor excision resulted in a myeloid-derived suppressor cell (MDSC) number increase from 12.4 cells/mu L to 16.2 cells/mu L in the HR group, and no change was detectable in LR patients (p = 0.12). An immune signature of postoperative recovery was more likely to occur in patients undergoing laparoscopic radical prostatectomy (LRP). Open RP (ORP) was associated with increased MDSC numbers (p = 0.002), whereas LRP was characterized by an immunity sparing profile, with no change in MDSC subset (p = 0.16). Conclusion: Tumor excision in prostate cancer patients results in two distinct patterns of immunophenotype rearrangement. The low-risk group is highly responsive, revealing postoperative restoration of T cells, NK cells, and CD8+ CD69+ numbers and the absence of suppressor MDSC increase. The high-risk group presented a limited response, accompanied by a suppressor MDSC increase and CD8+ CD69+ increase. The laparoscopic approach, unlike ORP, did not result in an MDSC increase in the postoperative period.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer
    Xin, Sheng
    Deng, Yuxuan
    Mao, Jiaquan
    Wang, Tao
    Liu, Jihong
    Wang, Shaogang
    Song, Xiaodong
    Song, Wen
    Liu, Xiaming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Role of serum response factor expression in prostate cancer biochemical recurrence
    Prencipe, Maria
    Fabre, Aurelie
    Murphy, Thomas Brendan
    Vargyas, Eszter
    O'Neill, Amanda
    Bjartell, Anders
    Tasken, Kristin Austlid
    Grytli, Helene H.
    Svindland, Aud
    Berge, Viktor
    Eri, Lars M.
    Gallagher, William
    Watson, R. William
    PROSTATE, 2018, 78 (10) : 724 - 730
  • [23] Circulating microRNAs predict biochemical recurrence in prostate cancer patients
    L A Selth
    S L Townley
    A G Bert
    P D Stricker
    P D Sutherland
    L G Horvath
    G J Goodall
    L M Butler
    W D Tilley
    British Journal of Cancer, 2013, 109 : 641 - 650
  • [24] Biochemical Recurrence Prediction in High-Risk Prostate Cancer Patients, Following Robot-Assisted Radical Prostatectomy
    Yamaguchi, Noriya
    Yumioka, Tetsuya
    Iwamoto, Hideto
    Masago, Toshihiko
    Morizane, Shuichi
    Honda, Masashi
    Sejima, Takehiro
    Takenaka, Atsushi
    YONAGO ACTA MEDICA, 2016, 59 (04) : 288 - 295
  • [25] Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer
    Leite, Katia R. M.
    Reis, Sabrina T.
    Viana, Nayara
    Morais, Denis R.
    Moura, Caio M.
    Silva, Iran A.
    Pontes, Jose, Jr.
    Katz, Betina
    Srougi, Miguel
    JOURNAL OF CANCER, 2015, 6 (03): : 292 - 301
  • [26] Imaging tumor lactate is feasible for identifying intermediate- risk prostate cancer patients with postsurgical biochemical recurrence
    Sushentsev, Nikita
    Hamm, Gregory
    Richings, Jack
    Mclean, Mary A.
    Menih, Ines Horvat
    Ayyappan, Vinay
    Cde, Ian G. Mills
    Warren, Anne Y.
    Warren, Y.
    Gnanapragasam, Vincent J.
    Barrett, Tristan
    Barry, Simon T.
    Goodwin, Richard J. A.
    Gallagher, Ferdia A.
    Barret, Tristan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (49)
  • [27] A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer
    Xia, Zhongyou
    Liu, Haolin
    Fan, Shicheng
    Tu, Hongtao
    Jiang, Yongming
    Wang, Hai
    Gu, Peng
    Liu, Xiaodong
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [28] Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy
    Feng, Dechao
    Shi, Xu
    Zhang, Facai
    Xiong, Qiao
    Wei, Qiang
    Yang, Lu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [29] Management of Patients with Biochemical Recurrence After Local Therapy for Prostate Cancer
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    Eisenberger, Mario A.
    Carducci, Michael A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (06) : 1205 - +
  • [30] The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs)
    Alashkham, Abduelmenem
    Paterson, Catherine
    Windsor, Phyllis
    Struthers, Allan
    Rauchhaus, Petra
    Nabi, Ghulam
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 398 - 405